Bayer Cropscience Ltd. - Research Center
506285 BAYERCROP Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | Mar ' 16 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 3,609.40 | 3,167.30 | 2,709.90 | 2,802.80 | 3,742.90 |
| Expenses | |||||
| Material consumed | 1,912.20 | 1,664.00 | 1,602.60 | 1,648.30 | 2,490.00 |
| Manufacturing expenses | 14.00 | 11.40 | 6.60 | 6.40 | 6.10 |
| Personnel expenses | 361.60 | 364.20 | 263.90 | 245.90 | 225.30 |
| Selling expenses | 198.20 | 212.50 | 153.50 | 151.00 | 168.70 |
| Adminstrative expenses | 397.00 | 434.10 | 273.90 | 337.60 | 433.60 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 2,883.00 | 2,686.20 | 2,300.50 | 2,389.20 | 3,323.70 |
| Operating profit | 726.40 | 481.10 | 409.40 | 413.60 | 419.20 |
| Other recurring income | 66.00 | 53.10 | 38.80 | 70.10 | 75.70 |
| Adjusted PBDIT | 792.40 | 534.20 | 448.20 | 483.70 | 494.90 |
| Financial expenses | 13.80 | 10.40 | 11.30 | 6.90 | 7.30 |
| Depreciation | 65.30 | 43.80 | 33.10 | 28.90 | 24.70 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 713.30 | 480.00 | 403.80 | 447.90 | 462.90 |
| Tax charges | 108.60 | 142.90 | 103.70 | 156.90 | 162.00 |
| Adjusted PAT | 604.70 | 337.10 | 300.10 | 291.00 | 300.90 |
| Non recurring items | -148.40 | -15.10 | -1.30 | -1.40 | - |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 456.30 | 322.00 | 298.80 | 289.60 | 300.90 |
| Earnigs before appropriation | 2,346.00 | 2,074.00 | 1,958.20 | 1,761.80 | 1,966.60 |
| Equity dividend | 80.00 | 100.60 | 47.90 | 47.90 | 48.30 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | 21.60 | 26.90 | 12.20 | 12.20 | 11.80 |
| Retained earnings | 2,244.40 | 1,946.50 | 1,898.10 | 1,701.70 | 1,906.50 |
Mutual Fund Selector
Find the fund that is right for you
© 2020 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis